The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1b/ 2 study of a radio-enhancer, PEP503 (NBTXR3), in combination with concurrent chemo-radiation in locally advanced or unresectable rectal cancer.
 
Ching-Wen Huang
No Relationships to Disclose
 
Jaw-Yuan Wang
No Relationships to Disclose
 
Chou-Pin Chen
No Relationships to Disclose
 
Po-Li Wei
No Relationships to Disclose
 
Huang-Ming Hu
No Relationships to Disclose
 
Wen-Hung Hsu
No Relationships to Disclose
 
Hsiang-Yao Shih
No Relationships to Disclose
 
Ming-Yii Huang
No Relationships to Disclose
 
Chiao-Yun Chen
No Relationships to Disclose
 
Chao-Hung Kuo
No Relationships to Disclose
 
Chou-Chen Chen
No Relationships to Disclose
 
Tzu-Wei Chiang
No Relationships to Disclose
 
Jeffrey Yung-Chuan Chao
No Relationships to Disclose
 
You-Hsin Chiu
No Relationships to Disclose
 
Cheng Tiong
No Relationships to Disclose
 
Pao-Ying Lin
No Relationships to Disclose
 
Long-Sheng Lu
No Relationships to Disclose
 
Ching-Huei Kung
No Relationships to Disclose
 
Wei-Che Yu
Employment - PharmaEngine
Stock and Other Ownership Interests - PharmaEngine
 
Yu-Shan Wu
Employment - PharmaEngine
Stock and Other Ownership Interests - PharmaEngine